期刊文献+

血清骨保护素与2型糖尿病及合并冠心病的关系 被引量:6

The relationship between osteoprotegerin and type 2 diabetes mellitus with or without coronary artery disease
下载PDF
导出
摘要 目的探讨血清骨保护素(OPG)与2型糖尿病及合并冠心病的关系。方法选择健康个体、2型糖尿病患者及2型糖尿病合并冠心病患者各30例。用ELISA方法测定OPG,生化法测定空腹血糖(FPG)及糖化血红蛋白(HbA1c),免疫化学发光法测定空腹胰岛素(FINS),计算胰岛素敏感指数(ISI)及胰岛素抵抗指数(HOMA-IR),并观察组间各指标的变化。结果 2型糖尿病组及合并冠心病组血清OPG、FPG、HbA1c、HOMA-IR明显高于对照组(P均<0.01),ISI明显低于对照组(P<0.01)。2型糖尿病合并冠心病组FINS显著高于对照组(P<0.05)。2型糖尿病组HbA1c明显高于2型糖尿病合并冠心病组(P<0.01)。结论 2型糖尿病及其合并冠心病患者血清OPG水平、血糖、胰岛素及HOMA-IR明显增高,2型糖尿病患者冠心病发生与血清OPG、血糖、胰岛素升高以及胰岛素抵抗有关,OPG作为心血管疾病的预测因子可能与胰岛素的影响有关。 Objective To investigate the relationship between osteoprotegerin (OPG)and type 2 diabetes mellitus(T2DM) with or without coronary artery disease (CAD).Methods The healthy individuals(control group), T2DM patients with or without CAD with 30 cases in each group were selected respectively .ELISA was used for deter-mination of OPG, biochemistry method for fasting blood glucose (FPG) and glycosylated hemoglobin (HbA1c), im-munochemical chemiluminescence for fasting insulin ( FINS) , insulin sensitivity index ( ISI) and insulin resistance in-dex(HOMA-IR) were calculated,and the data in all groups were observed .Results OPG, FPG,HbA1c and HOMA-IR in groups of T2DM with or without coronary artery disease were obviously higher than those in control group ( P〈0.01),and ISI was lower than that in control group (P〈0.01).FINS in the group of T2DM with CAD was higher than that in control group(P〈0.05).HbA1c in the group of T2DM was higher than that in the group of T2DM with CAD( P〈0.01 ) .Conclusion The level of serum OPG ,blood glucose ,insulin and insulin resistance index in groups of T2DM with or without CAD increase obviously .Development of CAD in T2DM patients relate to the increased level of OPG,blood glucose ,insulin and insulin resistance .OPG as a risk predictor of cardiovascular disease may be related to the effects of insulin .
出处 《中国临床新医学》 2014年第1期8-10,共3页 CHINESE JOURNAL OF NEW CLINICAL MEDICINE
基金 广西自然科学基金资助项目(编号:桂科回0832018)
关键词 骨保护素 2型糖尿病 冠心病 Osteoprotegerin (OPG) Type 2 diabetes mellitus (T2DM) Coronary artery disease (CAD)
  • 相关文献

参考文献11

  • 1Preis SR,Hwang SJ,Coady S. Trends in all-cause and cardio-vascular disease mortality among women and men with and without di-abetes mellitus in the Framingham Heart Study,1950 to 2005[J].{H}CIRCULATION,2009,(13):1728-1735.
  • 2陈晖,颜晓东.骨相关蛋白与糖尿病动脉钙化关系的研究进展[J].中国临床新医学,2013,6(10):1022-1025. 被引量:3
  • 3李光伟,Step.,L.检测人群胰岛素敏感性的一项新指数[J].中华内科杂志,1993,32(10):656-660. 被引量:2125
  • 4Browner WS,Lui LY,Cummings SR. Associations of serum osteopro-tegerin levels with diabetes,stroke,bone density,fracture,and mortali-ty in elderly women[J].J Clin Endocrlnol Metab,2001,(02):631-637.
  • 5向光大,孙慧伶,赵林双,徐琳.2型糖尿病患者护骨素与内皮依赖性血管舒张功能的关系[J].中华内分泌代谢杂志,2007,23(3):231-234. 被引量:3
  • 6Kim SM,Leet J,Ryu OH. Serum osteoprotegerin levels are as-sociated with inflammation and pulse wave velocity[J].Clin Endo-crinol(Oxf),2005,(05):594-598.
  • 7Knudsen ST,Foss CH,Poulsen PL. Increased plasma concen-trations of osteoprotegerin in type 2 diabetic patients with microvascu-lar complications[J].{H}European Journal of Endocrinology,2003,(01):39-42.
  • 8Avignon A,Sultan A,Piot C. Osteoprotegerin is associated with silent coronary artery disease in high risk but asymptomatic type 2 dia-betic patients[J].{H}DIABETES CARE,2005,(09):2176-2180.
  • 9J宝rgensen GM;Vind B;Nybo M.Acute hyperinsulinemia de-creases plasma osteoprotegerin with diminished effect in type 2 diabe-tes and obesity[J],{H}European Journal of Endocrinology20095-101.
  • 10Olesen P,Nguyen K,Wogensen L. Calcification of human vascular smooth muscle cells:associations with osteoprotegerin ex-pression and acceleration by high-dose insulin[J].{H}American Journal of Physiology Heart and Circulatory Physiology,2007,(02):1058-1064.

二级参考文献62

  • 1向光大,何玉生,蒋文,胡泰洪.女性2型糖尿病患者载脂蛋白e4等位基因与内皮依赖性血管舒张功能降低有关[J].中华内分泌代谢杂志,2005,21(1):9-12. 被引量:9
  • 2向光大,陈志松,邓胜平,戴晓婧,王平.1型糖尿病早期肱动脉内皮依赖性血管舒张功能已降低[J].中华内分泌代谢杂志,2005,21(1):18-20. 被引量:12
  • 3Simonet WS, Lacey DL, Dunstan CR, et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell, 1997, 89 : 309 -319.
  • 4Dhore CR, Cleutjens JP, Lutgens E, et al. Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques. Arterioscler Thromb Vas Biol, 2001,21:1998-2003.
  • 5Zhang J, Fu M, Myles D, et al. PDGF induces osteoprotegerin expression in vascular smooth muscle cells by multiple signal pathways. FEBS letters, 2002,521 : 180-184.
  • 6Jono S, Ikari Y, Shioi A, et al. Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease. Circulation, 2002,106 : 1192-1194.
  • 7Schoppet M, Sattler AM, Schaefer JR, et al. Increased osteoprotegerin serum levels in men with coronary artery disease, J Clin Endocrinol Metab, 2003,88 : 1024-1028.
  • 8Knudsen ST, Foss CH, Poulsen PL, et al. Increased plasma concentrations of osteoprotegerin in type 2 diabetic patients with microvascular complications. Eur J Endocrinol, 2003,149:39-42.
  • 9Avignon A, Sultan A, Piot C, et al. Osteoprotegerin is associated with silent coronary artery disease in high-risk but asymptomatic type 2 diabetic patients, Diabetes Care, 2005,28:2176-2180.
  • 10Browner WS, Lui LY, Cummings SR, Associations of serum osteoprotegerin levels with diabetes, stroke, bone density, fracture, and mortality in elderly women, J Clin Endocrinol Metab, 2001,86 : 631- 637.

共引文献2128

同被引文献69

  • 1沈兴平,李娟,严钟德.肥胖2型糖尿病患者血清E-选择素水平与氧化应激的关系[J].中国病理生理杂志,2006,22(10):2040-2043. 被引量:12
  • 2许勇,杨桦,乔建瓯,李西华,严兰珍,王龙,徐国江,费俭,傅继粱,王铸钢.骨保护素(Opg)基因敲除小鼠发生高转换型骨质疏松和动脉钙化(英文)[J].生物化学与生物物理进展,2007,34(3):260-266. 被引量:26
  • 3无.慢性稳定性心绞痛诊断与治疗指南[J].中华心血管病杂志,2007,35(3):195-206. 被引量:2045
  • 4柯元南,陈纪林.不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南[J].中华心血管病杂志,2007,35(4):295-304. 被引量:2113
  • 5Simonet WS,Lacey DL,Dunstall CR,et al.Osteoprotegerin:a novel secreted protein involved in the regulation of bone density[J].Cell,1997,89(2):309.
  • 6Vidal C,Formosa R,Xuereb-Anastasi A.Functional polymorphisms within the TNFRSF11B(osteoprotegerin)gene increase the risk for low bone mineral density[J].Journal of Molecular Endocrinology,2011,47(3):327-333.
  • 7郏蓉,纪立农.老年人BMD与OPG基因启动子区SNPs及骨代谢生化指标的相关分析研究[D].2011年北京医学会内分泌暨糖尿病学分会学术年会论文集,2011:128-129.
  • 8Roshandel D,Holliday KL,Pye SR,et al.Influence of polymorphisms in the RANKL/RANK/OPG signaling pathway on volumetric bone mineral density and bone geometry at the forearm in men[J].Calcified Tissue International,2011,89(6):446-455.
  • 9Luo Y,Hu Z,Hao J,et al.Significant Associations Between the A163G and G1181C Polymorphisms of the Osteoprotegerin Gene and Risk of Osteoporosis,Especially in Postmenopausal Women:A Meta-Analysis[J].Genetic Testing and Molecular Biomarkers,2014,18(3):211-219.
  • 10Chao TH,Yu HN,Huang CC,et al.Opposite associations of osteoprotegerin and ZBTB40 polymorphisms with bone mineral density of the hip in postmenopausal Taiwan Residents women[J].Journal of the Chinese Medical Association,2012,75(7):335-340.

引证文献6

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部